Tuesday, October 13, 2020

Keeping Track: Kadmon Chooses RTOR For Belumosudil; NDAs For Novel Imaging Agents And ...

Keeping Track: Pfizer's Talzenna Ensures Record Year For Novel US Approvals; Novartis Submits SMA Gene Therapy. 21 Oct 2018 ...
http://dlvr.it/RjVS42
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...